Enigma interacts with adaptor protein with PH and SH2 domains to control insulin-induced actin cytoskeleton remodeling and glucose transporter 4 translocation

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Enigma interacts with adaptor protein with PH and SH2 domains to control insulin-induced actin cytoskeleton remodeling and glucose transporter 4 translocation. / Barres, Romain; Grémeaux, Thierry; Gual, Philippe; Gonzalez, Teresa; Gugenheim, Jean; Tran, Albert; Le Marchand-Brustel, Yannick; Tanti, Jean-François.

In: Molecular Endocrinology, Vol. 20, No. 11, 11.2006, p. 2864-75.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Barres, R, Grémeaux, T, Gual, P, Gonzalez, T, Gugenheim, J, Tran, A, Le Marchand-Brustel, Y & Tanti, J-F 2006, 'Enigma interacts with adaptor protein with PH and SH2 domains to control insulin-induced actin cytoskeleton remodeling and glucose transporter 4 translocation', Molecular Endocrinology, vol. 20, no. 11, pp. 2864-75. https://doi.org/10.1210/me.2005-0455

APA

Barres, R., Grémeaux, T., Gual, P., Gonzalez, T., Gugenheim, J., Tran, A., Le Marchand-Brustel, Y., & Tanti, J-F. (2006). Enigma interacts with adaptor protein with PH and SH2 domains to control insulin-induced actin cytoskeleton remodeling and glucose transporter 4 translocation. Molecular Endocrinology, 20(11), 2864-75. https://doi.org/10.1210/me.2005-0455

Vancouver

Barres R, Grémeaux T, Gual P, Gonzalez T, Gugenheim J, Tran A et al. Enigma interacts with adaptor protein with PH and SH2 domains to control insulin-induced actin cytoskeleton remodeling and glucose transporter 4 translocation. Molecular Endocrinology. 2006 Nov;20(11):2864-75. https://doi.org/10.1210/me.2005-0455

Author

Barres, Romain ; Grémeaux, Thierry ; Gual, Philippe ; Gonzalez, Teresa ; Gugenheim, Jean ; Tran, Albert ; Le Marchand-Brustel, Yannick ; Tanti, Jean-François. / Enigma interacts with adaptor protein with PH and SH2 domains to control insulin-induced actin cytoskeleton remodeling and glucose transporter 4 translocation. In: Molecular Endocrinology. 2006 ; Vol. 20, No. 11. pp. 2864-75.

Bibtex

@article{226a1bf858ad4157935410ca93302ba8,
title = "Enigma interacts with adaptor protein with PH and SH2 domains to control insulin-induced actin cytoskeleton remodeling and glucose transporter 4 translocation",
abstract = "APS (adaptor protein with PH and SH2 domains) initiates a phosphatidylinositol 3-kinase-independent pathway involved in insulin-stimulated glucose transport. We recently identified Enigma, a PDZ and LIM domain-containing protein, as a partner of APS and showed that APS-Enigma complex plays a critical role in actin cytoskeleton organization in fibroblastic cells. Because actin rearrangement is important for insulin-induced glucose transporter 4 (Glut 4) translocation, we studied the potential involvement of Enigma in insulin-induced glucose transport in 3T3-L1 adipocytes. Enigma mRNA was expressed in differentiated adipocytes and APS and Enigma were colocalized with cortical actin. Expression of an APS mutant unable to bind Enigma increased the insulin-induced Glut 4 translocation to the plasma membrane. By contrast, overexpression of Enigma inhibited insulin-stimulated glucose transport and Glut 4 translocation without alterations in proximal insulin signaling. This inhibitory effect was prevented with the deletion of the LIM domains of Enigma. Using time-lapse fluorescent microscopy of green fluorescent protein-actin, we demonstrated that the overexpression of Enigma altered insulin-induced actin rearrangements, whereas the expression of Enigma without its LIM domains was without effect. A physiological link between increased expression of Enigma and an alteration in insulin-induced glucose uptake was suggested by the increase in Enigma mRNA expression in adipose tissue of diabetic obese patients. Taken together, these data strongly suggest that the interaction between APS and Enigma is involved in insulin-induced Glut 4 translocation by regulating cortical actin remodeling and raise the possibility that modification of APS/Enigma ratio could participate in the alteration of insulin-induced glucose uptake in adipose tissue.",
keywords = "3T3-L1 Cells, Actin Cytoskeleton, Adaptor Proteins, Signal Transducing, Adipose Tissue, Adult, Animals, Cytoskeletal Proteins, Diabetes Mellitus, Type 2, Female, Glucose, Glucose Transporter Type 4, Humans, Insulin, Intracellular Signaling Peptides and Proteins, LIM Domain Proteins, Male, Mice, Middle Aged, Obesity, Protein Binding, Protein Transport, RNA, Messenger, Thinness, Tissue Distribution, Transfection",
author = "Romain Barres and Thierry Gr{\'e}meaux and Philippe Gual and Teresa Gonzalez and Jean Gugenheim and Albert Tran and {Le Marchand-Brustel}, Yannick and Jean-Fran{\c c}ois Tanti",
year = "2006",
month = nov,
doi = "10.1210/me.2005-0455",
language = "English",
volume = "20",
pages = "2864--75",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "Oxford University Press",
number = "11",

}

RIS

TY - JOUR

T1 - Enigma interacts with adaptor protein with PH and SH2 domains to control insulin-induced actin cytoskeleton remodeling and glucose transporter 4 translocation

AU - Barres, Romain

AU - Grémeaux, Thierry

AU - Gual, Philippe

AU - Gonzalez, Teresa

AU - Gugenheim, Jean

AU - Tran, Albert

AU - Le Marchand-Brustel, Yannick

AU - Tanti, Jean-François

PY - 2006/11

Y1 - 2006/11

N2 - APS (adaptor protein with PH and SH2 domains) initiates a phosphatidylinositol 3-kinase-independent pathway involved in insulin-stimulated glucose transport. We recently identified Enigma, a PDZ and LIM domain-containing protein, as a partner of APS and showed that APS-Enigma complex plays a critical role in actin cytoskeleton organization in fibroblastic cells. Because actin rearrangement is important for insulin-induced glucose transporter 4 (Glut 4) translocation, we studied the potential involvement of Enigma in insulin-induced glucose transport in 3T3-L1 adipocytes. Enigma mRNA was expressed in differentiated adipocytes and APS and Enigma were colocalized with cortical actin. Expression of an APS mutant unable to bind Enigma increased the insulin-induced Glut 4 translocation to the plasma membrane. By contrast, overexpression of Enigma inhibited insulin-stimulated glucose transport and Glut 4 translocation without alterations in proximal insulin signaling. This inhibitory effect was prevented with the deletion of the LIM domains of Enigma. Using time-lapse fluorescent microscopy of green fluorescent protein-actin, we demonstrated that the overexpression of Enigma altered insulin-induced actin rearrangements, whereas the expression of Enigma without its LIM domains was without effect. A physiological link between increased expression of Enigma and an alteration in insulin-induced glucose uptake was suggested by the increase in Enigma mRNA expression in adipose tissue of diabetic obese patients. Taken together, these data strongly suggest that the interaction between APS and Enigma is involved in insulin-induced Glut 4 translocation by regulating cortical actin remodeling and raise the possibility that modification of APS/Enigma ratio could participate in the alteration of insulin-induced glucose uptake in adipose tissue.

AB - APS (adaptor protein with PH and SH2 domains) initiates a phosphatidylinositol 3-kinase-independent pathway involved in insulin-stimulated glucose transport. We recently identified Enigma, a PDZ and LIM domain-containing protein, as a partner of APS and showed that APS-Enigma complex plays a critical role in actin cytoskeleton organization in fibroblastic cells. Because actin rearrangement is important for insulin-induced glucose transporter 4 (Glut 4) translocation, we studied the potential involvement of Enigma in insulin-induced glucose transport in 3T3-L1 adipocytes. Enigma mRNA was expressed in differentiated adipocytes and APS and Enigma were colocalized with cortical actin. Expression of an APS mutant unable to bind Enigma increased the insulin-induced Glut 4 translocation to the plasma membrane. By contrast, overexpression of Enigma inhibited insulin-stimulated glucose transport and Glut 4 translocation without alterations in proximal insulin signaling. This inhibitory effect was prevented with the deletion of the LIM domains of Enigma. Using time-lapse fluorescent microscopy of green fluorescent protein-actin, we demonstrated that the overexpression of Enigma altered insulin-induced actin rearrangements, whereas the expression of Enigma without its LIM domains was without effect. A physiological link between increased expression of Enigma and an alteration in insulin-induced glucose uptake was suggested by the increase in Enigma mRNA expression in adipose tissue of diabetic obese patients. Taken together, these data strongly suggest that the interaction between APS and Enigma is involved in insulin-induced Glut 4 translocation by regulating cortical actin remodeling and raise the possibility that modification of APS/Enigma ratio could participate in the alteration of insulin-induced glucose uptake in adipose tissue.

KW - 3T3-L1 Cells

KW - Actin Cytoskeleton

KW - Adaptor Proteins, Signal Transducing

KW - Adipose Tissue

KW - Adult

KW - Animals

KW - Cytoskeletal Proteins

KW - Diabetes Mellitus, Type 2

KW - Female

KW - Glucose

KW - Glucose Transporter Type 4

KW - Humans

KW - Insulin

KW - Intracellular Signaling Peptides and Proteins

KW - LIM Domain Proteins

KW - Male

KW - Mice

KW - Middle Aged

KW - Obesity

KW - Protein Binding

KW - Protein Transport

KW - RNA, Messenger

KW - Thinness

KW - Tissue Distribution

KW - Transfection

U2 - 10.1210/me.2005-0455

DO - 10.1210/me.2005-0455

M3 - Journal article

C2 - 16803868

VL - 20

SP - 2864

EP - 2875

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 11

ER -

ID: 45577404